Work Package 10: Hitech medical resources
The overall objective of WP10 is to establish a NoE on emerging/innovative and/or privileged technologies in the cancer area to ensure optimal coverage of patient needs throughout the EU. Such technologies include biotherapies and advanced therapies, innovative surgical procedures, complex radiation equipment (e.g. hadron therapy), innovative therapeutic nuclear medicine solutions, interventional radiology techniques, early phase clinical research centers dedicated to first-in-human studies and the like. Overall, this NoE will ensure a link with the network of CCCs to progressively promote equitable access to these advanced technologies in the EU and MS.
The specific objectives will include the definition of:
- the scope of the NoE on hi-tech medical resources
- its activities
- its potential partners
- its governance
- its sustainability
- its indicators of efficacy and its cost/efficacy constraints
- its relationship with MSs, other EU and national networks, CCCs throughout the EU, patients.
Lead beneficiary: UNICANCER, Co-lead INCA